Skip to main content
Alligator Bioscience logo

Alligator Bioscience — Investor Relations & Filings

Ticker · ATORX ISIN · SE0024173637 LEI · 549300E15VI0MB7LXV19 ST Manufacturing
Open in API
Filings indexed 608 across all filing types
Latest filing 2025-05-08 Notice of Dividend Amou…
Country SE Sweden
Listing ST ATORX

About Alligator Bioscience

https://alligatorbioscience.se/en/

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.

Recent filings

Filing Released Lang Actions
Alligator Bioscience updates dividend policy
Notice of Dividend Amount Classification · 1% confidence The document is a press release titled "ALLIGATOR BIOSCIENCE UPDATES DIVIDEND POLICY". It explicitly announces a change in the company's dividend policy following a board meeting. This directly relates to the distribution of capital to shareholders, which falls under the scope of dividend announcements. Although it mentions the possibility of a 'dividend or repurchase of shares', the core subject is the policy update regarding shareholder distributions. This aligns best with the 'Notice of Dividend Amount' (DIV) category, as it concerns the framework for future shareholder payouts, even if it's a policy change rather than a specific amount declaration. Given the options, DIV is the most specific fit for a dividend policy update. The document is short and appears to be an announcement rather than a full statutory report.
2025-05-08 English
Kommuniké från årsstämma den 7 maj 2025 i Alligator Bioscience AB
AGM Information Classification · 1% confidence The document is explicitly titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA DEN 7 MAJ 2025 I ALLIGATOR BIOSCIENCE AB" (Communiqué from the Annual General Meeting on May 7, 2025, in Alligator Bioscience AB). It details the resolutions passed at the AGM, including the approval of accounts, discharge of directors, election of the board and auditor, approval of the remuneration report, and authorization for future share issues. These contents are characteristic of materials presented or summarized immediately following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document is a summary/communiqué, not a proxy statement (PSI) or a full annual report (10-K).
2025-05-07 Swedish
Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 2025
AGM Information Classification · 1% confidence The document is explicitly titled "BULLETIN FROM THE ANNUAL GENERAL MEETING IN ALLIGATOR BIOSCIENCE AB ON 7 MAY 2025". It details resolutions passed regarding the adoption of accounts, discharge from liability, election of board members and auditor, approval of the remuneration report, and authorization regarding share issues. These are all core activities and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length (6008 chars) is substantial enough to be the primary report/summary of the meeting, not just a brief announcement of publication.
2025-05-07 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding ('Innehavare', 'Transaktionen', 'Andel') for a specific instrument ('Aktier') by an entity ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') in Alligator Bioscience AB. It specifies the number of shares held before and after the transaction, the resulting percentage ownership ('5,24932 %'), and the date of the transaction (2025-04-30). This structure is characteristic of a notification regarding a change in significant share ownership, often referred to as a 'flagging notification' in Nordic contexts, which corresponds to the Major Shareholding Notification category.
2025-05-02 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage ('Andel innehavda aktier: 4,94439 %') and voting rights ('Andel rösträtter: 8,69559') for a specific instrument (Aktier) by an entity (Avanza Bank Holding AB). It explicitly mentions 'Gränsvärde för antal rösträtter: 5 %' being crossed due to the return of loaned shares ('Skäl för flaggning: Aktielån'). This structure—reporting changes in ownership thresholds for significant shareholders—is characteristic of a Major Shareholding Notification. In the provided definitions, 'Major Shareholding Notification' corresponds to code MRQ.
2025-05-02 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding (crossing a threshold) by Avanza Bank Holding AB in Alligator Bioscience AB. This falls under the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2025-05-02 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.